Changes in Inflammatory Cytokines After Chronic Hepatitis C Treatment Among People Living With HIV-Reference-Cited by-同舟云学术

Changes in Inflammatory Cytokines After Chronic Hepatitis C Treatment Among People Living With HIV

Published:2024-01 Issue:1 Volume:11 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Karimi-Sari Hamidreza¹^ORCID,Piggott Damani A¹²,Scully Eileen P¹^ORCID,Ward Kathleen¹,Sutcliffe Catherine G²³,Sulkowski Mark¹,Falade-Nwulia Oluwaseun¹^ORCID

Affiliation:

1. Division of Infectious Diseases, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA

2. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health , Baltimore, Maryland , USA

3. Department of International Health, Johns Hopkins Bloomberg School of Public Health , Baltimore, Maryland , USA

Abstract

Abstract We aimed to evaluate the effect of hepatitis C virus cure on serum inflammatory markers among people with HIV. Among 127 people with HIV, serum alanine aminotransferase, soluble tumor necrosis factor receptor 1, and inflammatory index score were significantly lower at the 24-week time point in patients who achieved sustained virologic response as compared with those who did not.

Funder

National Institutes of Health

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofad623/55023569/ofad623.pdf

Reference18 articles.

1. Abnormal levels of some biomarkers of immune activation despite very early treatment of human immunodeficiency virus;Schnittman;J Infect Dis,2021

2. Independent association of interleukin 6 with low dynamic lung function and airflow limitation in well-treated people with human immunodeficiency virus;Thudium;J Infect Dis,2021

3. Hepatitis C virus (HCV) direct-acting antiviral therapy in persons with human immunodeficiency virus—HCV genotype 1 coinfection resulting in high rate of sustained virologic response and variable in normalization of soluble markers of immune activation;Anthony;J Infect Dis,2020

4. Remodeling of immunological biomarkers in patients with chronic hepatitis C treated with direct-acting antiviral therapy;Ribeiro;Antiviral Res,2021

5. Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication;Lu;World J Gastroenterol,2022